UDD Logo
CRIS - Current Research Information System
New user? Click here to register.Have you forgotten your password?
Communities & Collections
Research Outputs
Fundings & Projects
Researchers
Datasets
Statistics
  1. Home
  2. CRIS
  3. Publications
  4. Major Histocompatibility Complex Class I-Related Chain A (MICA) Allelic Variants Associate With Susceptibility and Prognosis of Gastric Cancer
Details

Major Histocompatibility Complex Class I-Related Chain A (MICA) Allelic Variants Associate With Susceptibility and Prognosis of Gastric Cancer

Journal
Frontiers in Immunology
ISSN
1664-3224
Date Issued
2021
Author(s)
Karen Toledo-Stuardo
Carolina H. Ribeiro
Andrea Canals
Marcela Morales
Valentina Gárate
Jose Rodríguez-Siza
Samantha Tello
Marco Bustamante
ARMISEN YAÑEZ, RICARDO AMADO  
Facultad de Medicina Clínica Alemana Universidad del Desarrollo  
Douglas J. Matthies
Gerald Zapata-Torres
Patricio González-Hormazabal
María Carmen Molina
Type
Resource Types::text::journal::journal article
Scopus ID
2-s2.0-85104198294
WoS ID
WOS:000639981300001
DOI
10.3389/fimmu.2021.645528
URL
https://investigadores.udd.cl/handle/123456789/6520
URL Institutional Repository
http://hdl.handle.net/11447/4096
Abstract
<jats:p>Gastric cancer (GC) is the fifth most prevalent type of cancer worldwide. Gastric tumor cells express MICA protein, a ligand to NKG2D receptor that triggers natural killer (NK) cells effector functions for early tumor elimination. <jats:italic>MICA</jats:italic> gene is highly polymorphic, thus originating alleles that encode protein variants with a controversial role in cancer. The main goal of this work was to study <jats:italic>MICA</jats:italic> gene polymorphisms and their relationship with the susceptibility and prognosis of GC. Fifty patients with GC and 50 healthy volunteers were included in this study. MICA alleles were identified using Sanger sequencing methods. The analysis of <jats:italic>MICA</jats:italic> gene sequence revealed 13 MICA sequences and 5 MICA-short tandem repeats (STR) alleles in the studied cohorts We identified MICA<jats:sup>*</jats:sup>002 (<jats:sup>*</jats:sup>A9) as the most frequent allele in both, patients and controls, followed by MICA<jats:sup>*</jats:sup>008 allele (<jats:sup>*</jats:sup>A5.1). MICA<jats:sup>*</jats:sup>009/049 allele was significantly associated with increased risk of GC (OR: 5.11 [95% CI: 1.39–18.74], <jats:italic>p</jats:italic> = 0.014). The analysis of MICA-STR alleles revealed a higher frequency of MICA<jats:sup>*</jats:sup>A5 in healthy individuals than GC patients (OR = 0.34 [95% CI: 0.12–0.98], <jats:italic>p</jats:italic> = 0.046). Survival analysis after gastrectomy showed that patients with MICA<jats:sup>*</jats:sup>002/002 or MICA<jats:sup>*</jats:sup>002/004 alleles had significantly higher survival rates than those patients bearing MICA<jats:sup>*</jats:sup>002/008 (<jats:italic>p</jats:italic> = 0.014) or MICA<jats:sup>*</jats:sup>002/009 (MICA<jats:sup>*</jats:sup>002/049) alleles (<jats:italic>p</jats:italic> = 0.040). The presence of threonine in the position MICA-181 (MICA<jats:sup>*</jats:sup>009/049 allele) was more frequent in GC patients than controls (<jats:italic>p</jats:italic> = 0.023). Molecular analysis of MICA-181 showed that the presence of threonine provides greater mobility to the protein than arginine in the same position (MICA<jats:sup>*</jats:sup>004), which could explain, at least in part, some immune evasion mechanisms developed by the tumor. In conclusion, our findings suggest that the study of MICA alleles is crucial to search for new therapeutic approaches and may be useful for the evaluation of risk and prognosis of GC and personalized therapy.</jats:p>
Cite this document
Toledo-Stuardo, K., Ribeiro, C. H., Canals, A., Morales, M., Gárate, V., Rodríguez-Siza, J., Tello, S., Bustamante, M., Armisen, R., Matthies, D. J., Zapata-Torres, G., González-Hormazabal, P., & Molina, M. C. (2021). Major histocompatibility complex class i-related chain a (Mica) allelic variants associate with susceptibility and prognosis of gastric cancer. Frontiers in Immunology, 12, 645528. https://doi.org/10.3389/fimmu.2021.645528
Subjects
gastric cancer

; 

mica gene

; 

mica polymorphism

; 

mica-129

; 

mica alleles

; 

aged

; 

alleles

; 

female

; 

genetic predisposition to disease

; 

histocompatibility antigens class i

; 

humans

; 

male

; 

microsatellite repeats

; 

middle aged

; 

neoplasm proteins

; 

polymorphism, genetic

; 

stomach neoplasms

; 

hla antigen class 1

; 

mhc class i-related chain a

; 

microsatellite dna

; 

tumor protein

; 

aged

; 

allele

; 

clinical trial

; 

female

; 

genetic polymorphism

; 

genetic predisposition

; 

genetics

; 

human

; 

immunology

; 

male

; 

middle aged

; 

stomach tumor
Logo Universidad de Desarrollo
Encuéntranos en:

Sede Santiago

Av. Plaza 680, Las Condes

Contacto|Mapa

Sede Concepción

Ainavillo 456, Concepción

Contacto|Mapa

Hosting & SupportLogo Scimago Lab

Built with DSpace-CRIS software - Extension maintained and optimized by 4science

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify